The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast …
Simple Summary The 5-year survival rate for patients with breast cancer, in whom disease
has spread to local lymph nodes, is 85%. However, many live with the complications of …
has spread to local lymph nodes, is 85%. However, many live with the complications of …
[HTML][HTML] Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial …
S Cao, X Liu, J Cui, X Liu, J Zhong, Z Yang, D Sun… - The Breast, 2021 - Elsevier
Purpose Neoadjuvant chemotherapy (NACT) is increasingly adopted in the therapy of breast
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
AA van Loevezijn, MEM van der Noordaa… - Breast cancer research …, 2022 - Springer
Purpose In clinically node-positive (cN+) breast cancer patients, evidence supporting
response-guided treatment after neoadjuvant systemic therapy (NST) instead of axillary …
response-guided treatment after neoadjuvant systemic therapy (NST) instead of axillary …
Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic …
M Banys-Paluchowski, IV Gruber, A Hartkopf… - Archives of Gynecology …, 2020 - Springer
Purpose Data on the optimal treatment strategy for patients undergoing neoadjuvant therapy
(NAT) who initially presented with metastatic nodes and convert to node-negative disease …
(NAT) who initially presented with metastatic nodes and convert to node-negative disease …
Surgical management of the axilla for breast cancer
A Laws, O Kantor, TA King - Hematology/Oncology Clinics, 2023 - hemonc.theclinics.com
Background Historically, axillary clearance with axillary lymph node dissection (ALND) was
important for the regional control of breast cancer. However, with increasing rates of early …
important for the regional control of breast cancer. However, with increasing rates of early …
The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature …
G Ferrarazzo, A Nieri, E Firpo, A Rattaro, A Mignone… - Current …, 2023 - mdpi.com
Background: In clinically node-positive (cN+) breast cancer (BC) patients who become
clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph …
clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph …
Outcomes of sentinel node biopsy for women with breast cancer after neoadjuvant therapy: systematic review and meta-analysis of real-world data
Background Evidence on the accuracy of sentinel lymph node biopsy (SLNB) after
neoadjuvant therapy (NAT) for patients with breast cancer is inconclusive. This study …
neoadjuvant therapy (NAT) for patients with breast cancer is inconclusive. This study …
Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings
J Chavda, A Mishra, A Silodia, SK Yadav… - Breast Cancer Research …, 2022 - Springer
Background Sentinel lymph node biopsy (SLNB) using radio-pharmaceutical and a blue dye
is gold standard for axillary staging in clinically node-negative breast cancer. High costs and …
is gold standard for axillary staging in clinically node-negative breast cancer. High costs and …
Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant …
SB Lee, H Kim, J Kim, IY Chung, HJ Kim, BS Ko… - Plos one, 2021 - journals.plos.org
This study aimed to evaluate the prognosis of breast cancer patients who received
neoadjuvant chemotherapy and underwent sentinel lymph node biopsy (SLNB) alone as …
neoadjuvant chemotherapy and underwent sentinel lymph node biopsy (SLNB) alone as …
[HTML][HTML] The adventure of axillary treatment in early stage breast cancer
B Kuru - European Journal of Breast Health, 2020 - ncbi.nlm.nih.gov
Axillary lymph node dissection (ALND) which was an essential part of breast cancer
treatment and the gold standard in evaluation of the status of axillary lymph node had …
treatment and the gold standard in evaluation of the status of axillary lymph node had …